Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-010385

CytoDyn Inc. · CYDY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nader Pourhassan
Officer — President and CEO · Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)F1,F2$2.00Dec 21, 2015D500,000A—Jul 31, 2016Common Stock500,0000D
Stock Options (right to buy)F1,F2$2.00Dec 21, 2015A500,000A—Jul 31, 2021Common Stock500,000500,000D
Stock Options (right to buy)F1,F2$2.75Dec 21, 2015D54,545A—Mar 23, 2017Common Stock54,5450D
Stock Options (right to buy)F1,F2$2.75Dec 21, 2015A54,545A—Mar 23, 2022Common Stock54,54554,545D
Stock Options (right to buy)F1,F3$0.90Dec 21, 2015D200,000A—Jun 30, 2020Common Stock200,0000D
Stock Options (right to buy)F1,F3$0.90Dec 21, 2015A200,000A—Jun 30, 2025Common Stock200,000150,000D

Explanation of responses